• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Let's Stay BIOGEN STRONG!!!

anonymous

Guest
We must stick together to get through this rough patch. Screw all those those ADU haters out there....if we stay positive good things will come our way!

Let's WIN together!!!!
 








And remember to give COVID to everyone you meet!

Well sn't that pleasant....

Yeah, I'm out busting my tail knocking on doors for MS patients. MS Doesn't stop because of covid. Doing the best I can to keep myself and my family safe while still honoring my commitment to Biogen and the patients we serve.

I appreciate the positive thread. So many negative cancerous people on here.
 












Adu meets an unmet need in the alz marketplace. Biogen has 600 mil bucks behind it seeing that it gets launched. You trolls who did not get hired here just need to go away. You can continue to cry like little girls but that won’t stop Adu from launching.
 
















Says the bitter troll who got cut from the hiring process. Unmet clinical need and 600 mil vs your bitter personal opinion. You’re a moron!

The company has no clue if they will get approved. If you think these messages are coming from outside, you are nuts. There are tons of internal people that just want this to be over. So think again.
 




The company has no clue if they will get approved. If you think these messages are coming from outside, you are nuts. There are tons of internal people that just want this to be over. So think again.


And neither do you have a clue. Truth be told Your sorry azz is in the darkest room of anybody with your knowledge or lack there of.